HIV-1 infection and central monoamine neurotransmitters

Adarsh Kumar, J. B. Fernandez, Irina Borodowsky, Louis Gonzalez, Mahendra Kumar

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Human immunodeficiency virus type 1 (HIV-1) enters the central nervous system (CNS) shortly after infection and gets localized in different brain regions, leading to various types of neuropathological problems. It has been hypothesized that HIV-1 infection mediated neuropathogenesis may also adversely affect the activity of the central monoamine neurotransmitters systems, such as dopamine (DA), and 5-hydroxytryptamine (5-HT, serotonin), resulting in neurocognitive deficits and mental health problems. However, investigations are scarce with respect to the status of these neurotransmitters in the CNS of HIV-1+ individuals, particularly in those patients who had received antiretroviral therapy (ART) during life. Since, mental health problems and neurocognitive and neuropsychological deficits continue to persist even after ART intervention, it is pertinent to determine the CNS status of the neurotransmitters associated with these functions. We determined the neurotransmitters, dopamine and its metabolite, homovanillic acid (HVA) in different brain regions of a group of autopsied cases of HIV-1+ and HIV-1 negative controls, using highly sensitive CoulArray HPLC-ECD system. Distribution of HIV-1 viral RNA in these brain regions was also measured using real-time reverse transcriptase polymerase chain reaction (real-time RT-PCR) technology with high sensitivity of detection (<5 copies of RNA). In a separate study we reported measurement of 5-HT (serotonin) and its metabolite, 5-hydroxyindole acetic acid (5-HIAA) in the cerebrospinal fluid (CSF) obtained during life of neurologically asymptomatic HIV-1 infected patients and controls. A substantial decrease and a wide variation in the concentration of DA as well as its metabolite, homovanillic acid (HVA) was found in the autopsied brain regions of HIV-1 infected individuals. Wide variation was also found in HIV-1 RNA concentrations in different brain regions with no specific pattern observed in any region. Brain regions of HIV- negative individuals showed no detectable viral RNA. Majority of HIV-1+ individuals had demonstrated neurocognitive impairment during life despite ART intervention. A significant decrease in 5-HT concentration was also found in the CSF of HIV-1 infected patients. These studies demonstrate that HIV-1 infection adversely affects the central DA and 5-HT systems.

Original languageEnglish
Pages (from-to)177-183
Number of pages7
JournalAmerican Journal of Infectious Diseases
Volume3
Issue number4
StatePublished - Dec 1 2007

Fingerprint

Virus Diseases
Neurotransmitter Agents
HIV-1
Serotonin
Dopamine
Brain
Homovanillic Acid
Central Nervous System
Viral RNA
Cerebrospinal Fluid
Real-Time Polymerase Chain Reaction
Mental Health
RNA
Reverse Transcriptase Polymerase Chain Reaction
Acetic Acid
Therapeutics
High Pressure Liquid Chromatography
HIV
Technology

Keywords

  • CNS
  • HIV-1
  • Monoamine neurotransmitters

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Kumar, A., Fernandez, J. B., Borodowsky, I., Gonzalez, L., & Kumar, M. (2007). HIV-1 infection and central monoamine neurotransmitters. American Journal of Infectious Diseases, 3(4), 177-183.

HIV-1 infection and central monoamine neurotransmitters. / Kumar, Adarsh; Fernandez, J. B.; Borodowsky, Irina; Gonzalez, Louis; Kumar, Mahendra.

In: American Journal of Infectious Diseases, Vol. 3, No. 4, 01.12.2007, p. 177-183.

Research output: Contribution to journalArticle

Kumar, A, Fernandez, JB, Borodowsky, I, Gonzalez, L & Kumar, M 2007, 'HIV-1 infection and central monoamine neurotransmitters', American Journal of Infectious Diseases, vol. 3, no. 4, pp. 177-183.
Kumar A, Fernandez JB, Borodowsky I, Gonzalez L, Kumar M. HIV-1 infection and central monoamine neurotransmitters. American Journal of Infectious Diseases. 2007 Dec 1;3(4):177-183.
Kumar, Adarsh ; Fernandez, J. B. ; Borodowsky, Irina ; Gonzalez, Louis ; Kumar, Mahendra. / HIV-1 infection and central monoamine neurotransmitters. In: American Journal of Infectious Diseases. 2007 ; Vol. 3, No. 4. pp. 177-183.
@article{7954c822a0ee40a28baa3a00f6db9896,
title = "HIV-1 infection and central monoamine neurotransmitters",
abstract = "Human immunodeficiency virus type 1 (HIV-1) enters the central nervous system (CNS) shortly after infection and gets localized in different brain regions, leading to various types of neuropathological problems. It has been hypothesized that HIV-1 infection mediated neuropathogenesis may also adversely affect the activity of the central monoamine neurotransmitters systems, such as dopamine (DA), and 5-hydroxytryptamine (5-HT, serotonin), resulting in neurocognitive deficits and mental health problems. However, investigations are scarce with respect to the status of these neurotransmitters in the CNS of HIV-1+ individuals, particularly in those patients who had received antiretroviral therapy (ART) during life. Since, mental health problems and neurocognitive and neuropsychological deficits continue to persist even after ART intervention, it is pertinent to determine the CNS status of the neurotransmitters associated with these functions. We determined the neurotransmitters, dopamine and its metabolite, homovanillic acid (HVA) in different brain regions of a group of autopsied cases of HIV-1+ and HIV-1 negative controls, using highly sensitive CoulArray HPLC-ECD system. Distribution of HIV-1 viral RNA in these brain regions was also measured using real-time reverse transcriptase polymerase chain reaction (real-time RT-PCR) technology with high sensitivity of detection (<5 copies of RNA). In a separate study we reported measurement of 5-HT (serotonin) and its metabolite, 5-hydroxyindole acetic acid (5-HIAA) in the cerebrospinal fluid (CSF) obtained during life of neurologically asymptomatic HIV-1 infected patients and controls. A substantial decrease and a wide variation in the concentration of DA as well as its metabolite, homovanillic acid (HVA) was found in the autopsied brain regions of HIV-1 infected individuals. Wide variation was also found in HIV-1 RNA concentrations in different brain regions with no specific pattern observed in any region. Brain regions of HIV- negative individuals showed no detectable viral RNA. Majority of HIV-1+ individuals had demonstrated neurocognitive impairment during life despite ART intervention. A significant decrease in 5-HT concentration was also found in the CSF of HIV-1 infected patients. These studies demonstrate that HIV-1 infection adversely affects the central DA and 5-HT systems.",
keywords = "CNS, HIV-1, Monoamine neurotransmitters",
author = "Adarsh Kumar and Fernandez, {J. B.} and Irina Borodowsky and Louis Gonzalez and Mahendra Kumar",
year = "2007",
month = "12",
day = "1",
language = "English",
volume = "3",
pages = "177--183",
journal = "American Journal of Infectious Diseases",
issn = "1553-6203",
publisher = "Science Publications",
number = "4",

}

TY - JOUR

T1 - HIV-1 infection and central monoamine neurotransmitters

AU - Kumar, Adarsh

AU - Fernandez, J. B.

AU - Borodowsky, Irina

AU - Gonzalez, Louis

AU - Kumar, Mahendra

PY - 2007/12/1

Y1 - 2007/12/1

N2 - Human immunodeficiency virus type 1 (HIV-1) enters the central nervous system (CNS) shortly after infection and gets localized in different brain regions, leading to various types of neuropathological problems. It has been hypothesized that HIV-1 infection mediated neuropathogenesis may also adversely affect the activity of the central monoamine neurotransmitters systems, such as dopamine (DA), and 5-hydroxytryptamine (5-HT, serotonin), resulting in neurocognitive deficits and mental health problems. However, investigations are scarce with respect to the status of these neurotransmitters in the CNS of HIV-1+ individuals, particularly in those patients who had received antiretroviral therapy (ART) during life. Since, mental health problems and neurocognitive and neuropsychological deficits continue to persist even after ART intervention, it is pertinent to determine the CNS status of the neurotransmitters associated with these functions. We determined the neurotransmitters, dopamine and its metabolite, homovanillic acid (HVA) in different brain regions of a group of autopsied cases of HIV-1+ and HIV-1 negative controls, using highly sensitive CoulArray HPLC-ECD system. Distribution of HIV-1 viral RNA in these brain regions was also measured using real-time reverse transcriptase polymerase chain reaction (real-time RT-PCR) technology with high sensitivity of detection (<5 copies of RNA). In a separate study we reported measurement of 5-HT (serotonin) and its metabolite, 5-hydroxyindole acetic acid (5-HIAA) in the cerebrospinal fluid (CSF) obtained during life of neurologically asymptomatic HIV-1 infected patients and controls. A substantial decrease and a wide variation in the concentration of DA as well as its metabolite, homovanillic acid (HVA) was found in the autopsied brain regions of HIV-1 infected individuals. Wide variation was also found in HIV-1 RNA concentrations in different brain regions with no specific pattern observed in any region. Brain regions of HIV- negative individuals showed no detectable viral RNA. Majority of HIV-1+ individuals had demonstrated neurocognitive impairment during life despite ART intervention. A significant decrease in 5-HT concentration was also found in the CSF of HIV-1 infected patients. These studies demonstrate that HIV-1 infection adversely affects the central DA and 5-HT systems.

AB - Human immunodeficiency virus type 1 (HIV-1) enters the central nervous system (CNS) shortly after infection and gets localized in different brain regions, leading to various types of neuropathological problems. It has been hypothesized that HIV-1 infection mediated neuropathogenesis may also adversely affect the activity of the central monoamine neurotransmitters systems, such as dopamine (DA), and 5-hydroxytryptamine (5-HT, serotonin), resulting in neurocognitive deficits and mental health problems. However, investigations are scarce with respect to the status of these neurotransmitters in the CNS of HIV-1+ individuals, particularly in those patients who had received antiretroviral therapy (ART) during life. Since, mental health problems and neurocognitive and neuropsychological deficits continue to persist even after ART intervention, it is pertinent to determine the CNS status of the neurotransmitters associated with these functions. We determined the neurotransmitters, dopamine and its metabolite, homovanillic acid (HVA) in different brain regions of a group of autopsied cases of HIV-1+ and HIV-1 negative controls, using highly sensitive CoulArray HPLC-ECD system. Distribution of HIV-1 viral RNA in these brain regions was also measured using real-time reverse transcriptase polymerase chain reaction (real-time RT-PCR) technology with high sensitivity of detection (<5 copies of RNA). In a separate study we reported measurement of 5-HT (serotonin) and its metabolite, 5-hydroxyindole acetic acid (5-HIAA) in the cerebrospinal fluid (CSF) obtained during life of neurologically asymptomatic HIV-1 infected patients and controls. A substantial decrease and a wide variation in the concentration of DA as well as its metabolite, homovanillic acid (HVA) was found in the autopsied brain regions of HIV-1 infected individuals. Wide variation was also found in HIV-1 RNA concentrations in different brain regions with no specific pattern observed in any region. Brain regions of HIV- negative individuals showed no detectable viral RNA. Majority of HIV-1+ individuals had demonstrated neurocognitive impairment during life despite ART intervention. A significant decrease in 5-HT concentration was also found in the CSF of HIV-1 infected patients. These studies demonstrate that HIV-1 infection adversely affects the central DA and 5-HT systems.

KW - CNS

KW - HIV-1

KW - Monoamine neurotransmitters

UR - http://www.scopus.com/inward/record.url?scp=38849143123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38849143123&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:38849143123

VL - 3

SP - 177

EP - 183

JO - American Journal of Infectious Diseases

JF - American Journal of Infectious Diseases

SN - 1553-6203

IS - 4

ER -